California Press Releases

Published on January 13, 2025 - 13:00 GMT

Day One Reports Preliminary 2024 OJEMDA™ Net Product Revenue and Highlights 2025 Corporate Priorities

Preliminary 2024 OJEMDA™ (tovorafenib) net product revenue of approximately $57.2 million (unaudited) First dose cohort cleared in Phase 1a/b clinical trial of DAY301 (PTK7-targeted ADC) Ended 2024 with approximately $531.7 million in cash, cash …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2025 - 13:00 GMT

ARS Pharmaceuticals Announces Preliminary Fourth Quarter 2024 Financial Results and 2025 Objectives for neffy® (epinephrine nasal ...

Preliminary fourth quarter neffy® net product revenue of approximately $6.5 million Preliminary cash, cash equivalents and short-term investments of $314.0 million at year-end 2024 to support an operating runway of at least three years Company to present …

Distribution channels:

Published on January 13, 2025 - 13:00 GMT

Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results

Preliminary Q4 2024 revenue expected to be between $7.9 and $8.1 million, which would represent an estimated decrease of approximately 25% over Q4 2023 due primarily to discontinuation of clinical service products in 2024 Installed base of optical genome …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2025 - 13:00 GMT

Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for ...

FDA Breakthrough Therapy Designation received for tividenofusp alfa for Hunter syndrome (MPS II); on track to submit biologics license application (BLA) in early 2025 Preparing for commercial launch of tividenofusp alfa for Hunter syndrome in late 2025 or …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on January 13, 2025 - 12:30 GMT

Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic ...

BURLINGAME, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 13, 2025 - 12:30 GMT

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030

PDUFA Target Action Date for Aficamten Set for September 26, 2025; Commercial Launch Preparations Underway for First Potential Approval Five-Year Aspirations Outline Corporate Strategies to Becoming Leading Muscle Biology Specialty Biopharma Company SOUTH …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 13, 2025 - 12:00 GMT

Nurix Therapeutics Outlines 2025 Goals and Objectives for Advancement of Its Robust Pipeline in Cancer and Autoimmune Diseases

Initiate a suite of clinical trials in 2025 intended to support global registration of NX-5948 for the treatment of chronic lymphocytic leukemia Expand the development of NX-5948 in additional cancer indications and inflammatory diseases Advance our …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 13, 2025 - 12:00 GMT

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Preliminary, unaudited revenue for the full year 2024 of approximately $174 million Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16th, 2024, at 9:45 a.m. PT. SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 (GLOBE …

Distribution channels:

Published on January 13, 2025 - 12:00 GMT

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Completed enrollment in Phase 2 BESTOW trial assessing tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Presented updated data on 13 participants from ongoing Phase 1b trial …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 13, 2025 - 12:00 GMT

Skye Bioscience Provides 2025 Look Ahead and Year in Review

SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company developing new therapeutic pathways for metabolic health, enters 2025 positioned to announce Phase 2 data for nimacimab, …

Distribution channels: Technology ...

Published on January 12, 2025 - 23:40 GMT

SAG-AFTRA called on by Chuck Slavin to pivot Awards Amid LA WildFires: Solidarity and Support for Members in Crisis

Chuck Slavin Calls for Pivot in SAG-AFTRA Awards Amid Devastating LA Fires: Solidarity and Support for Members in Crisis LOS ANGELES, CA, UNITED STATES, January 12, 2025 /⁨EINPresswire.com⁩/ -- In light of the catastrophic fires ravaging Los Angeles and …

Distribution channels: Human Rights, Media, Advertising & PR ...

Published on January 13, 2025 - 10:50 GMT

RIG INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Transocean Ltd. Investors with Substantial Losses Have ...

SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Transocean Ltd. (NYSE: RIG) securities between October 31, 2023 and September 2, 2024, all dates inclusive (the “Class Period”), …

Distribution channels: Consumer Goods, Law ...

Published on January 12, 2025 - 20:13 GMT

OkayCoin Expands Crypto Staking Services with Enhanced Features for Broader Accessibility

LOS ANGELES, CA, UNITED STATES, January 12, 2025 /⁨EINPresswire.com⁩/ -- OkayCoin, a reliable cryptocurrency staking platform, has unveiled a series of updates to its staking services, aiming to make blockchain participation and earning crypto staking …

Distribution channels: ...

Published on January 13, 2025 - 03:55 GMT

PACS Investors Have Opportunity to Lead PACS Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Jan. 12, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against PACS Group, Inc. (“PACS” or “the Company”) (NYSE: PACS) for violations of the federal …

Distribution channels:

Published on January 12, 2025 - 23:20 GMT

With eye toward L.A.’s recovery, Governor Newsom issues executive order directing fast action to clear debris, prepare for ...

The Governor announced this latest executive order following tours of the devastation caused by the Eaton and Palisades fires, with stops in Altadena and the Pacific Palisades this morning. While there, he met with first responders and wildfire survivors. …

Distribution channels:

Published on January 12, 2025 - 21:39 GMT

Governor Newsom deploys an additional 1,000 California National Guard service members to Los Angeles fires

State’s all-in response With this newest deployment, California has mobilized more than 15,000+ personnel including firefighters, guard service members, highway patrol officers and transportation teams to support the ongoing firefight. In addition, these …

Distribution channels:

Published on January 12, 2025 - 16:00 GMT

Ultragenyx Reports Preliminary 2024 Revenue, Financial Guidance for 2025, Pipeline Updates, and 2025 Milestones

Preliminary 2024 total revenue of $555 million to $560 million, exceeding top end of guidance, including Crysvita® revenue of $405 million to $410 million, and Dojolvi® revenue of $87 million to $89 million 2025 expected total revenue guidance of $640 …

Distribution channels:

Published on January 12, 2025 - 14:59 GMT

Governor Newsom signs executive order to help Los Angeles rebuild faster and stronger

The executive order issued by Governor Newsom will: Suspend CEQA review and California Coastal Act permitting for reconstruction of properties substantially damaged or destroyed in recent Southern California wildfires. Direct state agencies to identify …

Distribution channels:

Published on January 12, 2025 - 13:30 GMT

Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Revenues of Approximately $63 ...

Preliminary unaudited product revenue for the fourth quarter of 2024 is expected to be approximately $63 million, up approximately 366% vs. Q4 2023 and 41% vs. Q3 2024 Preliminary unaudited product revenue for the full-year 2024 is expected to be …

Distribution channels:

Published on January 11, 2025 - 19:07 GMT

LA Toy Store Launches Fundraising Effort to Provide Toys for Children Displaced by LA County Fires

Adventuretown Toy Emporium is raising funds to provide toys for children displaced by LA County fires, bringing comfort and joy through play. LOS ANGELES, CA, UNITED STATES, January 11, 2025 /⁨EINPresswire.com⁩/ -- In response to the unprecedented …

Distribution channels: Culture, Society & Lifestyle ...

California Press Releases Distributed by EIN Presswire